Faculty:

Nicolas W. Shammas, MS, MD
Director, Midwest Cardiovascular Research Foundation
Davenport, IA

David E. Allie, MD
Director of Cardiothoracic and Endovascular Surgery
Director of Peripheral Vascular Studies
Cardiovascular Institute of the South/Lafayette
Lafayette, LA

Mark Wholey, MD
Central Cardiovascular Institute of San Antonio
San Antonio, TX

---

Topics:

Module 1: Direct Thrombin Inhibition During Peripheral Vascular Interventions
Nicolas W. Shammas, MS, MD

Module 2: Use of Direct Thrombin Inhibitors during PPI for CLI, SFA and Fem-Pop Intervention
David E. Allie, MD

Module 3: Adjunctive Pharmacology During Carotid Artery Stenting
Mark Wholey, MD

---

Target Audience:

This activity is designed for Invasive Cardiologists, Vascular Surgeons, Interventional Neurologists, Interventional Radiologists, Nurses and Technologists.

---

Learning Objectives:

Module 1: Direct Thrombin Inhibition During Peripheral Vascular Interventions

Upon completion of this educational activity, participants should be able to:

• Review the rationale to use direct thrombin inhibitors in the periphery
  
• Review clinical data that support the use of bivalirudin in peripheral vascular interventions

Module 2: Use of Direct Thrombin Inhibitors during PPI for CLI, SFA and Fem-Pop Intervention

Upon completion of this educational activity, participants should be able to:

• Discuss the clinical impact of CLI
  
• Discuss the role of antithrombins therapy and anticoagulation in the role of limb salvage

Module 3: Adjunctive Pharmacology During Carotid Artery Stenting

Upon completion of this educational activity, participants should be able to:

• discuss the basics of pharmacology in carotid stent placement including preparation, intraprocedural and post-stent medical therapy
• review medical management of complications intraprocedurally during carotid stent placement
• describe possible drug alternatives for future therapy

---

Accreditation:

Module 1: Direct Thrombin Inhibition During Peripheral Vascular Interventions

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits ™. Each physician should claim only those credits that he/she actually spent in the educational activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-03.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.

Radiologic Technologists:
This activity has been approved for one hour of SICP credit.

Module 2: Use of Direct Thrombin Inhibitors during PPI for CLI, SFA and Fem-Pop Intervention

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Each physician should claim only those credits that he/she actually spent in the educational activity.

This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-03.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.

Radiologic Technologists:
This activity has been approved for one hour of SICP credit.

Module 3: Adjunctive Pharmacology During Carotid Artery Stenting
Off-Label/Unapproved Usage Discussion:
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the North American Center for Continuing Medical Education, nor The Medicines Company recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Each physician should claim only those credits that he/she actually spent in the educational activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

Nurses:
ANCC: North American Center for Continuing Medical Education is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1 contact hour. Provider #: 110-3-E-03.

Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 1 contact hour.

Radiologic Technologists:
Activities approved by the American Medical Association (AMA Category 1) are eligible for ARRT Category B credit as long as they are relevant to the radiologic sciences. Radiologic Technologists, registered by the ARRT, may claim up to 12 Category B credits per biennium.

---

Faculty Disclosures:

Module 1: Direct Thrombin Inhibition During Peripheral Vascular Interventions

All faculty participating in continuing education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Dr. Shammas has disclosed that he has received grant/research support and is a member of the speakers’ bureau for The Medicines Company.

Module 2: Use of Direct Thrombin Inhibitors during PPI for CLI, SFA and Fem-Pop Intervention

All faculty participating in continuing education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Dr. Allie has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of his presentation.

Module 3: Adjunctive Pharmacology During Carotid Artery Stenting

All faculty participating in continuing education programs sponsored by the North American Center for Continuing Medical Education are expected to disclose to the meeting audience any real or apparent conflict(s) of interest related to the content of their presentation. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants

Dr. Wholey has disclosed that he is is a scientific advisor for Edwards Lifesciences.

---

Commercial Supporter:

This activity is supported by an educational grant from The Medicines Company.

---

Sponsor:

Sponsored by the North American Center for Continuing Medical Education (NACCME).